These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10335720)

  • 1. Successful implementation of guidelines for encouraging the use of beta blockers in patients after acute myocardial infarction.
    Sarasin FP; Maschiangelo ML; Schaller MD; Héliot C; Mischler S; Gaspoz JM
    Am J Med; 1999 May; 106(5):499-505. PubMed ID: 10335720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D; Paris BE; Aronow WS
    J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
    Bruggmann C; Iglesias JF; Gex-Fabry M; Fesselet R; Vogt P; Sadeghipour F; Voirol P
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):105-115. PubMed ID: 31300969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.
    Martínez M; Agustí A; Arnau JM; Vidal X; Laporte JR
    Eur J Clin Pharmacol; 1998 May; 54(3):203-8. PubMed ID: 9681660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival.
    Weightman WM; Gibbs NM; Sheminant MR; Whitford EG; Mahon BD; Newman MA
    Anesth Analg; 1999 Feb; 88(2):286-91. PubMed ID: 9972742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.
    Shlipak MG; Browner WS; Noguchi H; Massie B; Frances CD; McClellan M
    Am J Med; 2001 Apr; 110(6):425-33. PubMed ID: 11331052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA; Lauzon C; Eisenberg MJ; Huynh T; Dion D; Roux R; Racine N; Carignan S; Diodati JG; Charbonneau F; Lévesque C; Pouliot J J; Pilote L L
    Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers, angiotensin-converting enzyme inhibitors, and calcium antagonists in treatment of elderly patients with acute myocardial infarction.
    Aronow WS
    Coron Artery Dis; 2000 Jun; 11(4):331-8. PubMed ID: 10860176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital.
    Mitra S; Findley K; Frohnapple D; Mehta JL
    Clin Cardiol; 2002 Jan; 25(1):16-8. PubMed ID: 11808833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive beneficial effects of beta blockers in the prevention of symptomatic heart failure.
    Genovesi Ebert A; Colivicchi F; Malvezzi Caracciolo M; Riccio C
    Monaldi Arch Chest Dis; 2009 Mar; 72(1):18-22. PubMed ID: 19645208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific profile and referral bias of rehabilitated patients after an acute coronary syndrome.
    Cottin Y; Cambou JP; Casillas JM; Ferrières J; Cantet C; Danchin N
    J Cardiopulm Rehabil; 2004; 24(1):38-44. PubMed ID: 14758102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials versus clinical practice in the secondary prevention of myocardial infarction.
    Agustí A; Arnau JM; Laporte JR
    Eur J Clin Pharmacol; 1994; 46(2):95-9. PubMed ID: 7913683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary prevention of ischemic heart disease: pharmacological treatment after myocardial infarction according to follow-up protocol].
    Milvidaite I; Luksiene D; Slapikiene B; Babarskiene MR; Liukaitis V; Maciulaitis R; Kadusevicius E; Pilviniene R
    Medicina (Kaunas); 2007; 43(2):131-6. PubMed ID: 17329948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.